Xylem Says Project Timing and Cautious Spending Impacted Third-Quarter Revenue
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
Week Ahead: Midterms, Earnings, Geopolitics, Bank Rates, & Treasury Refunding - What Could Go Wrong?
H impact | EARNINGS | Oct 30, 2026, 08:30 PM UTC
Federated Hermes Reports 3Q 2026 Revenue of $507.3M
Revenue rose 8.1% year over year to $507.3 million, while net income increased 7.5% to $111.9 million and diluted EPS rose 11.9% to $1.50. The company said equity revenue and the F
M impact | EARNINGS | Oct 30, 2026, 08:22 PM UTC
DoorDash Reports 3Q 2026 Revenue of $4.62B, Net Income of $466M
DoorDash reported diluted EPS of $1.06. Revenue, net income and EPS increased 34%, 91% and 92.7%, respectively, from the prior-year quarter; revenue growth was primarily driven by
M impact | EARNINGS | Oct 30, 2026, 08:21 PM UTC
Wall Street Falls on Tech Slump
US stock indices closed sharply on Friday amid a major selloff in technology shares. The S&P 500 fell 1.8%, the Nasdaq tumbled 3.5%, and the Dow lost 572 points following disappoin
H impact | EARNINGS | Oct 30, 2026, 08:14 PM UTC
Amphenol Reports 2026 Revenue of $10.23 Billion, EPS of $0.79
Revenue rose 65.1% year over year to $10.23 billion, net income increased 63.3% to $2.03 billion, and diluted EPS rose 61.2% to $0.79.
M impact | EARNINGS | Oct 30, 2026, 08:13 PM UTC
Eli Lilly Shares Rise 3.41% as Sales Outlook Improves, EPS Guidance Falls
Eli Lilly shares climbed 3.41% to $1,420.53 at 1:10 p.m. ET on October 30 as investors weighed higher sales expectations against a lower earnings outlook.
H impact | EARNINGS | Oct 30, 2026, 08:06 PM UTC